Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:10 pm Unchanged | 2024-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | Venrock Healthcare Capital Partners III, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-02-13 3:25 pm Purchase | 2024-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 2,373,404 11.400% | 167,058 (+7.57%) | Filing History |
| 2024-12-17 5:11 pm Purchase | 2024-12-17 | 13G | Adverum Biotechnologies, Inc. ADVM | Rush Ryan Bradford | 1,050,000 5.100% | 1,050,000 (New Position) | Filing History |
| 2024-11-14 6:57 pm Purchase | 2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM | Vivo Opportunity Fund Holdings L.P. | 218,895 1.100% | 218,895 (New Position) | Filing History |
| 2024-11-14 6:40 pm Purchase | 2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM | Logos Global Management LP | 416,666 2.000% | 416,666 (New Position) | Filing History |
| 2024-11-14 4:05 pm Unchanged | 2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM | COMMODORE CAPITAL LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-12 09:50 am Purchase | 2024-11-08 | 13G | Adverum Biotechnologies, Inc. ADVM | FMR LLC | 234,718 1.128% | 234,718 (New Position) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM | BlackRock Inc. BLK | 1,490,709 7.200% | 0 (Unchanged) | Filing History |
| 2024-11-06 5:49 pm Purchase | 2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM | MORGAN STANLEY MS | 78,862 0.400% | 78,862 (New Position) | Filing History |
| 2024-10-31 12:41 pm Purchase | 2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM | FRANKLIN RESOURCES INC BEN | 1,760,056 8.500% | 1,760,056 (New Position) | Filing History |
| 2024-10-30 9:34 pm Purchase | 2024-10-29 | 13G | Adverum Biotechnologies, Inc. ADVM | Stern Augustus | 1,116,628 5.370% | 1,116,628 (New Position) | Filing History |
| 2024-10-23 1:34 pm Purchase | 2024-10-22 | 13G | Adverum Biotechnologies, Inc. ADVM | Principia Wealth Advisory LLC | 1,055,103 5.070% | 1,055,103 (New Position) | Filing History |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM | BlackRock Inc. BLK | 1,490,709 7.200% | 1,490,709 (New Position) | Filing History |
| 2024-07-22 4:24 pm Purchase | 2024-07-17 | 13G | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 2,206,346 10.600% | 1,065,346 (+93.37%) | Filing History |
| 2024-05-14 5:06 pm Sale | 2024-03-21 | 13D | Adverum Biotechnologies, Inc. ADVM | Versant Ventures IV LLC | 500,387 2.400% | -2 (-0.00%) | Filing History |
| 2024-04-29 4:10 pm Purchase | 2024-04-18 | 13G | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 1,141,000 5.500% | 655,575 (+135.05%) | Filing History |
| 2024-02-22 3:47 pm Purchase | 2024-02-06 | 13G | Adverum Biotechnologies, Inc. ADVM | Logos Global Management LP | 1,500,000 7.200% | 1,500,000 (New Position) | Filing History |
| 2024-02-15 4:17 pm Purchase | 2024-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM | TCG Crossover GP II, LLC | 2,076,357 9.900% | 2,076,357 (New Position) | Filing History |
| 2024-02-14 8:26 pm Purchase | 2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | Venrock Healthcare Capital Partners III, L.P. | 1,556,421 7.500% | 966,472 (+163.82%) | Filing History |
| 2024-02-14 4:30 pm Purchase | 2024-02-07 | 13G | Adverum Biotechnologies, Inc. ADVM | Vivo Opportunity Fund Holdings L.P. | 1,500,000 7.200% | 1,500,000 (New Position) | Filing History |